Sponsored
Sponsored
Media Summary: Across the country, more front-line health care workers will vaccinated Wednesday. And we could be just days away from a ... The Forum offers an exciting opportunity for the public to view the unique scientific research and collaborative efforts of This presentation reviewed the comparative analyses (CA) process and provided key principles for conducting effective ...

Fda Clears Path For 2nd - Detailed Analysis & Overview

Across the country, more front-line health care workers will vaccinated Wednesday. And we could be just days away from a ... The Forum offers an exciting opportunity for the public to view the unique scientific research and collaborative efforts of This presentation reviewed the comparative analyses (CA) process and provided key principles for conducting effective ... This presentation described the purpose of informed consent and explained how two provisions in Dr. Dinko Rekic of Astra-Zeneca shows how the This presentation covered GDUFA-III implementation updates related to facility assessments, including pre-submission facility ...

Prescription drugs go through many steps and phases before they're approved by the Presentation jointly hosted by PIcc & DPA June 22, 2022. Air date: Wednesday, February 1, 2023, 12PM Description: The Introduction to the Principles and Practice of Clinical Research ... Ksenia Blinova and Alexandre J. S. Ribeiro discuss dissolution issues and examined OGD's bioequivalence evaluation based on the totality of evidence for this case. The session ... J. Paul Phillips provides an overview of the

Marty Makary and Vinay Prasad tried to reform the View our 2022 Digital Transformation Symposium Webpage to review the Agenda for the Day

Photo Gallery

FDA Clears Path For 2nd Coronavirus Vaccine, This One From Moderna | TODAY
Generic Drugs Forum (GDF) 2026 - Day 2
2023 FDA Science Forum - Day 2: Sessions 6 and 8
GDF 2024 | D2S03-2 - Comparative Analyses Update
REdI 2024 | D2S02-1 - Improving Informed Consent
Module 7 – Case Study 3: Acceleration of Phase 2 Study through the MIDD Pilot Program
GDF 2024 | D2S11-2 - GDUFA-III Implementation –Facility Related Updates
How does the FDA approve new drugs?
Decision Summary: Lessons from the first FDA Approval of an AI Tool in Diagnostic Pathology
FDA Webinar on New Infant Formula Transition Plan (Part 2)
FDA Product Regulations Part 2 of 7
Plenary: Regulatory Research at FDA (2/14) REdI 2017
View Detailed Profile
FDA Clears Path For 2nd Coronavirus Vaccine, This One From Moderna | TODAY

FDA Clears Path For 2nd Coronavirus Vaccine, This One From Moderna | TODAY

Across the country, more front-line health care workers will vaccinated Wednesday. And we could be just days away from a ...

Generic Drugs Forum (GDF) 2026 - Day 2

Generic Drugs Forum (GDF) 2026 - Day 2

This premier event brings together

Sponsored
2023 FDA Science Forum - Day 2: Sessions 6 and 8

2023 FDA Science Forum - Day 2: Sessions 6 and 8

The Forum offers an exciting opportunity for the public to view the unique scientific research and collaborative efforts of

GDF 2024 | D2S03-2 - Comparative Analyses Update

GDF 2024 | D2S03-2 - Comparative Analyses Update

This presentation reviewed the comparative analyses (CA) process and provided key principles for conducting effective ...

REdI 2024 | D2S02-1 - Improving Informed Consent

REdI 2024 | D2S02-1 - Improving Informed Consent

This presentation described the purpose of informed consent and explained how two provisions in

Sponsored
Module 7 – Case Study 3: Acceleration of Phase 2 Study through the MIDD Pilot Program

Module 7 – Case Study 3: Acceleration of Phase 2 Study through the MIDD Pilot Program

Dr. Dinko Rekic of Astra-Zeneca shows how the

GDF 2024 | D2S11-2 - GDUFA-III Implementation –Facility Related Updates

GDF 2024 | D2S11-2 - GDUFA-III Implementation –Facility Related Updates

This presentation covered GDUFA-III implementation updates related to facility assessments, including pre-submission facility ...

How does the FDA approve new drugs?

How does the FDA approve new drugs?

Prescription drugs go through many steps and phases before they're approved by the

Decision Summary: Lessons from the first FDA Approval of an AI Tool in Diagnostic Pathology

Decision Summary: Lessons from the first FDA Approval of an AI Tool in Diagnostic Pathology

Presentation jointly hosted by PIcc & DPA June 22, 2022.

FDA Webinar on New Infant Formula Transition Plan (Part 2)

FDA Webinar on New Infant Formula Transition Plan (Part 2)

The U.S. Food & Drug Administration (

FDA Product Regulations Part 2 of 7

FDA Product Regulations Part 2 of 7

Air date: Wednesday, February 1, 2023, 12PM Description: The Introduction to the Principles and Practice of Clinical Research ...

Plenary: Regulatory Research at FDA (2/14) REdI 2017

Plenary: Regulatory Research at FDA (2/14) REdI 2017

Ksenia Blinova and Alexandre J. S. Ribeiro discuss

FDA Strategy 2025 Policy, Pressures and the Path to MedTech Clearance | leanRAQA Live

FDA Strategy 2025 Policy, Pressures and the Path to MedTech Clearance | leanRAQA Live

What's really happening inside the

GDF2025 - D2S09 - Questions & Panel Discussion - Session Two

GDF2025 - D2S09 - Questions & Panel Discussion - Session Two

The Generic Drugs Forum's

AGDD 2024 | D2S05-1-Totality of Evidence Including Physiologically Based Pharmacokinetic Modeling...

AGDD 2024 | D2S05-1-Totality of Evidence Including Physiologically Based Pharmacokinetic Modeling...

dissolution issues and examined OGD's bioequivalence evaluation based on the totality of evidence for this case. The session ...

Overview of FDA's Expanded Access Program (13/14) REdI 2017

Overview of FDA's Expanded Access Program (13/14) REdI 2017

J. Paul Phillips provides an overview of the

CDER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CDER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the

Fixing the FDA: a two-track plan to end regulatory chaos

Fixing the FDA: a two-track plan to end regulatory chaos

Marty Makary and Vinay Prasad tried to reform the

2022 FDA Virtual Digital Transformation Symposium – Day 2 Afternoon Session

2022 FDA Virtual Digital Transformation Symposium – Day 2 Afternoon Session

View our 2022 Digital Transformation Symposium Webpage to review the Agenda for the Day

Related Video Content

Food and Drug Administration - Wikipedia information

The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human...

What does the Food and Drug Administration (FDA) do? - USAFacts information

The Food and Drug Administration (FDA) is a subdivision of the US Department of Health and Human Services responsible...

U.S. Food and Drug Administration | Silver Spring MD - Facebook information

The official page of the U.S. Food and Drug Administration. Our posts are all FDA APPROVED!

Food and Drug Administration | Description, History, Activities ... information

May 22, 2026 · Food and Drug Administration (FDA), agency of the U.S. federal government authorized by Congress to...

What Is the FDA? - WebMD information

Sep 14, 2025 · Learn how the Food and Drug Administration, or FDA, works to keep people safe by regulating foods,...

Sponsored